CSL PHARMA-ADVICE ApS Financials, key figures and credit report
Gross profit 30.6 kDKK FY 2022 +188.2% vs 2021
EBIT 30.6 kDKK FY 2022 +188.2% vs 2021
Net debt - 127.5 kDKK FY 2022 +53.4% vs 2021
Quick ratio 21.2 FY 2022 -6 vs 2021
Income statement (kDKK)
2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 399.61 | 261.33 | 143.18 | ||
| External services | - 119.07 | -80.81 | -48.20 | -34.69 | 30.60 |
| Gross profit | 280.54 | 180.52 | 94.98 | -34.69 | 30.60 |
| EBIT | 280.54 | 180.52 | 94.98 | -34.69 | 30.60 |
| Other financial income | 4.00 | ||||
| Other financial expenses | -4.15 | -3.04 | -3.14 | -9.84 | 1.89 |
| Pre-tax profit | 280.39 | 177.48 | 91.83 | -44.53 | 32.50 |
| Income taxes | -66.05 | -42.90 | -21.12 | ||
| Net earnings | 214.34 | 134.58 | 70.72 | -44.53 | 32.50 |
Assets (kDKK)
2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current other receivables | 7.46 | 16.76 | 15.62 | 3.05 | 3.04 |
| Current deferred tax assets | 7.69 | 10.00 | |||
| Short term receivables total | 7.46 | 16.76 | 23.32 | 3.05 | 13.04 |
| Cash and bank deposits | 582.15 | 538.83 | 426.22 | 273.51 | 127.48 |
| Cash and cash equivalents | 582.15 | 538.83 | 426.22 | 273.51 | 127.48 |
| Balance sheet total (assets) | 589.61 | 555.60 | 449.54 | 276.56 | 140.52 |
Equity and liabilities (kDKK)
2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Shares repurchased | 200.00 | 130.00 | 110.00 | 100.00 | |
| Retained earnings | 81.28 | 165.62 | 190.20 | 160.91 | 51.39 |
| Profit of the financial year | 214.34 | 134.58 | 70.72 | -44.53 | 32.50 |
| Shareholders equity total | 545.62 | 480.20 | 420.91 | 266.39 | 133.89 |
| Non-current liabilities total | |||||
| Current trade creditors | 28.63 | 10.17 | 6.63 | ||
| Short-term deferred tax liabilities | 43.89 | 75.40 | |||
| Other non-interest bearing current liabilities | 0.09 | ||||
| Current liabilities total | 43.99 | 75.40 | 28.63 | 10.17 | 6.63 |
| Balance sheet total (liabilities) | 589.61 | 555.60 | 449.54 | 276.56 | 140.52 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated